Problem of PPIs complicated by COVID-19
While recent studies have suggested that physicians should be careful when using proton-pump inhibitors (PPIs) in patients hospitalized with COVID-19, none have shown a causal relationship between PPIs and COVID-19 infection or severity.
A feature story in the April ACP Hospitalist looked into the growing body of literature that has raised questions about whether proton-pump inhibitors may be tied to an increased risk for SARS-CoV-2 infection or if they could worsen outcomes for patients hospitalized with COVID-19.